Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6091) 6091
Newsletter (53) 53
Magazine Article (36) 36
Book Chapter (20) 20
Book / eBook (12) 12
Dissertation (9) 9
Book Review (3) 3
Newspaper Article (3) 3
Government Document (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4599) 4599
life sciences & biomedicine (4453) 4453
humans (4180) 4180
fluoxetine - therapeutic use (3760) 3760
male (3258) 3258
fluoxetine (2879) 2879
female (2846) 2846
psychiatry (2525) 2525
biological and medical sciences (2110) 2110
adult (2068) 2068
medical sciences (2051) 2051
pharmacology. drug treatments (1629) 1629
pharmacology & pharmacy (1624) 1624
serotonin uptake inhibitors - therapeutic use (1572) 1572
animals (1550) 1550
neurosciences & neurology (1547) 1547
psychology. psychoanalysis. psychiatry (1508) 1508
middle aged (1424) 1424
neurosciences (1310) 1310
psychopharmacology (1308) 1308
neuropharmacology (1286) 1286
antidepressants (1230) 1230
depressive disorder - drug therapy (1188) 1188
fluoxetine - pharmacology (1167) 1167
treatment outcome (1107) 1107
fluoxetine - adverse effects (1102) 1102
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (1064) 1064
depression (1013) 1013
antidepressive agents, second-generation - therapeutic use (902) 902
antidepressive agents - therapeutic use (869) 869
adolescent (862) 862
double-blind method (752) 752
rats (718) 718
aged (702) 702
clinical neurology (673) 673
serotonin (641) 641
depression, mental (628) 628
psychology (628) 628
psychopathology. psychiatry (627) 627
social sciences (618) 618
depression - drug therapy (603) 603
fluoxetine - administration & dosage (563) 563
serotonin uptake inhibitors - pharmacology (563) 563
psychiatric status rating scales (556) 556
mice (553) 553
depressive disorder, major - drug therapy (549) 549
drug therapy (544) 544
mental depression (540) 540
dose-response relationship, drug (536) 536
depressive disorder - psychology (525) 525
drug therapy, combination (502) 502
adult and adolescent clinical studies (495) 495
serotonin uptake inhibitors - adverse effects (485) 485
abridged index medicus (451) 451
analysis (444) 444
antidepressive agents - pharmacology (413) 413
research (409) 409
child (408) 408
mood disorders (408) 408
disease models, animal (402) 402
time factors (385) 385
care and treatment (355) 355
psychology, clinical (347) 347
serotonin uptake inhibitors (336) 336
rats, sprague-dawley (331) 331
drug administration schedule (320) 320
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer (308) 308
obsessive-compulsive disorder - drug therapy (303) 303
behavior, animal - drug effects (296) 296
sertraline (293) 293
neurology (291) 291
antidepressant (289) 289
drugs (286) 286
paroxetine (285) 285
serotonin uptake inhibitors - administration & dosage (285) 285
anxiety (282) 282
drug interactions (279) 279
antidepressive agents, second-generation - adverse effects (275) 275
paroxetine - therapeutic use (273) 273
severity of illness index (272) 272
combined modality therapy (271) 271
health aspects (259) 259
clinical trials (257) 257
antidepressive agents, tricyclic - therapeutic use (253) 253
rats, wistar (250) 250
rodents (250) 250
follow-up studies (245) 245
analysis of variance (234) 234
pediatrics (233) 233
brain (230) 230
general & internal medicine (222) 222
antidepressive agents - adverse effects (216) 216
serotonin - metabolism (216) 216
antipsychotic agents - therapeutic use (212) 212
hippocampus - drug effects (212) 212
medicine, general & internal (212) 212
randomized controlled trials as topic (211) 211
antidepressive agents, second-generation - pharmacology (210) 210
pharmacology (208) 208
placebos (208) 208
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Mississauga - Stacks (3) 3
University College (Laidlaw) - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Online Resources - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Toronto East General Hospital - Chaplain Dept. (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6058) 6058
French (56) 56
Spanish (36) 36
German (28) 28
Russian (26) 26
Portuguese (25) 25
Chinese (19) 19
Polish (16) 16
Dutch (13) 13
Italian (11) 11
Japanese (6) 6
Turkish (4) 4
Hebrew (3) 3
Hungarian (3) 3
Norwegian (3) 3
Swedish (3) 3
Afrikaans (1) 1
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Therapeutic options for treatment-resistant depression
by Shelton, Richard C and Osuntokun, Olawale and Heinloth, Alexandra N and Corya, Sara A
CNS drugs, ISSN 1172-7047, 2010, Volume 24, Issue 2, pp. 131 - 161
Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Humans | Psychotherapy | Psychotropic Drugs - administration & dosage | Treatment Outcome | Clinical Trials as Topic | Vagus Nerve Stimulation | Transcranial Magnetic Stimulation | Depression - drug therapy | Deep Brain Stimulation | Antidepressive Agents - administration & dosage | Electroconvulsive Therapy | Depression - therapy | Drug Therapy, Combination | Drug Resistance
Journal Article
Details down arrow
2. Full Text Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple‐treatments meta‐analysis
by Taylor, D. M and Cornelius, V and Smith, L and Young, A. H
Acta psychiatrica Scandinavica, ISSN 0001-690X, 12/2014, Volume 130, Issue 6, pp. 452 - 469
antipsychotics | antidepressives | bipolar disorder | depression | Antipsychotics | Bipolar disorder | Depression | Antidepressives | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Miscellaneous | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Biological and medical sciences | Medical sciences | Neuropharmacology | Bipolar disorders | Psycholeptics: tranquillizer, neuroleptic | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Mood disorders | Triazines - therapeutic use | Humans | Thiazoles - therapeutic use | Aripiprazole | Depression - drug therapy | Dibenzothiazepines - therapeutic use | Lurasidone Hydrochloride | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Isoindoles - therapeutic use | Adult | Valproic Acid - therapeutic use | Fluoxetine - therapeutic use | Drug Therapy, Combination | Monoamine Oxidase Inhibitors - therapeutic use | Quetiapine Fumarate | Serotonin Uptake Inhibitors - therapeutic use | Treatment Outcome | Piperazines - therapeutic use | Bipolar Disorder - drug therapy | Bipolar Disorder - psychology | Randomized Controlled Trials as Topic | Antidepressive Agents - therapeutic use | Lithium Compounds - therapeutic use | Depression - psychology | Benzodiazepines - therapeutic use | Oxidases | Olanzapine | Fluoxetine | Mania | Comparative analysis | Drug therapy | Psychotropic drugs | Psychotherapy | Mental depression | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Combination pharmacotherapy for the treatment of fibromyalgia in adults
by Gilron, Ian and Thorpe, Joelle and Shum, Bonnie and Moore, R Andrew and Wiffen, Philip J and Gilron, Ian
Cochrane library, ISSN 1469-493X, 02/2018, Volume 2020, Issue 10, pp. CD010585 - CD010585
Melatonin | Chronic non-cancer pain | Soft tissue disorders | Soft tissue [rheumatism, rheumatic disease, bursitis, tendonitis] | Fibromyalgia | Antidepressive Agents | Pregabalin | 2019 3. Chronic pain | 5-Hydroxytryptophan | Fibromylagia | Muscle Relaxants, Central | Magnesium | Pharmacological therapies | Drug Therapy, Combination | Anti-Inflammatory Agents, Non-Steroidal | Amitriptyline | Fluoxetine | Rheumatology | Monoamine Oxidase Inhibitors | Pain & anaesthesia | Benzodiazepines | Randomized Controlled Trials as Topic | Treatment of Fibromyalgia | 2019 3.2 Fibromyalgia | Neurology | Acetaminophen | Duloxetine Hydrochloride | Carisoprodol | Malates | Medicine General & Introductory Medical Sciences | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Monoamine Oxidase Inhibitors - therapeutic use | Duloxetine Hydrochloride - therapeutic use | Pregabalin - therapeutic use | Humans | Carisoprodol - therapeutic use | Magnesium - therapeutic use | Antidepressive Agents - therapeutic use | Drug Therapy, Combination - methods | 5-Hydroxytryptophan - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Fibromyalgia - drug therapy | Melatonin - therapeutic use | Adult | Amitriptyline - therapeutic use | Acetaminophen - therapeutic use | Fluoxetine - therapeutic use | Benzodiazepines - therapeutic use | Malates - therapeutic use | Muscle Relaxants, Central - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials
by Hayasaka, Yu and Purgato, Marianna and Magni, Laura R and Ogawa, Yusuke and Takeshima, Nozomi and Cipriani, Andrea and Barbui, Corrado and Leucht, Stefan and Furukawa, Toshi A
Journal of affective disorders, ISSN 0165-0327, 2015, Volume 180, pp. 179 - 184
Psychiatry | Dose equivalence | Major depression | Fluoxetine | Antidepressive agents | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Fluvoxamine - therapeutic use | Double-Blind Method | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Male | Treatment Outcome | Paroxetine - therapeutic use | Evidence-Based Medicine | Moclobemide - therapeutic use | Randomized Controlled Trials as Topic | Antidepressive Agents - therapeutic use | Dose-Response Relationship, Drug | Nortriptyline - therapeutic use | Sertraline - therapeutic use | Adult | Citalopram - therapeutic use | Female | Amitriptyline - therapeutic use | Fluoxetine - therapeutic use | Bupropion - therapeutic use | Depressive Disorder, Major - drug therapy | Antidepressants, Tricyclic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Update of EULAR recommendations for the treatment of systemic sclerosis
by Kowal-Bielecka, Otylia and Fransen, Jaap and Avouac, Jerome and Becker, Mike and Kulak, Agnieszka and Allanore, Yannick and Distler, Oliver and Clements, Philip and Cutolo, Maurizio and Czirjak, Laszlo and Damjanov, Nemanja and del Galdo, Francesco and Denton, Christopher P and Distler, Jörg H W and Foeldvari, Ivan and Figelstone, Kim and Frerix, Marc and Furst, Daniel E and Guiducci, Serena and Hunzelmann, Nicolas and Khanna, Dinesh and Matucci-Cerinic, Marco and Herrick, Ariane L and van den Hoogen, Frank and van Laar, Jacob M and Riemekasten, Gabriela and Silver, Richard and Smith, Vanessa and Sulli, Alberto and Tarner, Ingo and Tyndall, Alan and Welling, Joep and Wigley, Frederic and Valentini, Gabriele and Walker, Ulrich A and Zulian, Francesco and Müller-Ladner, Ulf and EUSTAR Coauthors
Annals of the rheumatic diseases, ISSN 0003-4967, 08/2017, Volume 76, Issue 8, pp. 1327 - 1339
Systemic Sclerosis | Cyclophosphamide | Treatment | Methotrexate | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Glucocorticoids - therapeutic use | Pyrazoles - therapeutic use | Humans | Gastrointestinal Diseases - etiology | Lung Diseases - therapy | Raynaud Disease - etiology | Hypertension, Pulmonary - therapy | Lung Diseases - etiology | Scleroderma, Systemic - therapy | Delphi Technique | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Raynaud Disease - therapy | Fingers | Scleroderma, Systemic - complications | Phosphodiesterase 5 Inhibitors - therapeutic use | Fluoxetine - therapeutic use | Ulcer - etiology | Ulcer - therapy | Europe | Serotonin Uptake Inhibitors - therapeutic use | Hematopoietic Stem Cell Transplantation | Gastrointestinal Diseases - therapy | Prostaglandins I - therapeutic use | Pyrimidines - therapeutic use | Kidney Diseases - therapy | Kidney Diseases - etiology | Endothelin Receptor Antagonists - therapeutic use | Hypertension, Pulmonary - etiology | Endothelin | Experts | Fluoxetine | Lung diseases | Clinical trials | Stem cell transplantation | Transplantation | Prostacyclin | Patients | Pulmonary hypertension | Literature reviews | Studies | Systemic sclerosis | Ulcers | Skin diseases | Scleroderma | Phosphodiesterase | Kidney transplantation | Index Medicus | Rheumatology and Autoimmunity | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Reumatologi och inflammation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights